Skip to main content
. Author manuscript; available in PMC: 2018 Jun 3.
Published in final edited form as: Neuroscience. 2017 Apr 7;352:204–215. doi: 10.1016/j.neuroscience.2017.03.059

Figure 2.

Figure 2

(A) Representative Western blots and densitometry analysis of IDE, NAP and LRP1 in CCF-STTG1 cells after 3 and 7 days treatment with Aβo, oleocanthal, or combination. None of the treatments altered these proteins expression. (B) Representative Western blots and densitometry analysis of ABCA1 in CCF-STTG1 cells after 3 and 7 days treatment with Aβo, oleocanthal, or combination. ABCA1 was significantly up-regulated by Aβo treatment for 3 and 7 days; oleocanthal addition didn’t significantly alter ABCA1 expression. Data is presented as mean ± SD (*P<0.05, **P<0.01, ***P<0.001), n= 3 independent experiments.